Search - tctmd.com

Displaying 341 - 360 of 462

Sort: Relevancy | Date

Presentation TVT 2014

Critique and Comments from the European Guidelines Chairman

Presenter: Alec S. Vahanian

June 05, 2014

Presentation TVT 2014

2014 ACC/AHA Aortic Valve Guidelines: Aligning Definitions of Aortic Stenosis Severity with Treatment Recommendations

Presenter: Catherine M. Otto

June 05, 2014

Presentation Fellows 2014

State-of-the-Art in ACS and STEMI: Risk Stratification, Reperfusion Strategies, and Guidelines

Presenter: Gregg Stone

April 12, 2014

Presentation ECHO 2014

Guidelines for Performing a Comprehensive Transesophageal Echocardiographic Examination

Presenter: Rebecca T. Hahn

April 11, 2014

Presentation CTO 2014

Left Main Revascularization in the United States: Guidelines, Appropriate Use Criteria, and Standards of Care

Presenter: Jeffrey W. Moses

March 01, 2014

Presentation CTO 2014

European Standards for Left Main Revascularization: Does Clinical Practice Mirror Guidelines?

Presenter: Marie-Claude Morice

March 01, 2014

Presentation

Appropriateness of Diagnostic Catheterization for Suspected CAD in NY State

Presenter: Edward L. Hannan

February 05, 2014

Presentation TCT 2013

The Current US Guidelines Are Poorly Conceived! What Is Really Required to Be an Optimal TAVR Site?

Presenter: Mathew Williams

October 31, 2013

Presentation TCT 2013

The DAPT Duration Dilemma: Recent Trials and Reasonable Guidelines for Clinical Practice

Presenter: Dean Kereiakes

October 31, 2013

Presentation TCT 2013

Guidelines for Commercial TAVR Site Selection in the United States

Presenter: Rhonda Robb

October 31, 2013

Presentation TCT 2013

Medical Device Industry Perspectives

Presenter: Michael Mussallem

October 30, 2013

Presentation TCT 2013

From Evidence-Based Medicine to Guidelines (and Appropriate Use Criteria) to Clinical Practice

Presenter: Robert Harrington

October 30, 2013

Presentation TCT 2013

Welcome and Introduction: The Purpose of the FDA Town Hall Meeting

Presenter: Martin Leon

October 30, 2013

Presentation TCT 2013

Status Update on European Medical Device Regulatory Reform Initiatives

Presenter: Alan Fraser

October 30, 2013

Presentation TCT 2013

Keynote Address: The Intersection of Innovation, Payment and Regulatory Approval in the Future of Interventional Cardiology

Presenter: Jack Lewin

October 30, 2013

Presentation TCT 2013

Keynote Address: FDA-CDRH in the Next Decade – A Vision for Change

Presenter: Christy Foreman

October 30, 2013

Presentation TCT 2013

Interventional Cardiovascular Medicine Perspectives

Presenter: Martin Leon

October 30, 2013

Presentation TCT 2013

FDA-CDRH Perspectives

Presenter: Matthew Hillebrenner

October 30, 2013

Presentation TCT 2013

Enlightened Perspectives from NICE

Presenter: Amanda Adler

October 30, 2013

Presentation TCT 2013

Cool and Cath: Critical Appraisal of the New Guidelines

Presenter: Timothy Henry

October 30, 2013

Advertisement

Critique and Comments from the European Guidelines Chairman

2014 ACC/AHA Aortic Valve Guidelines: Aligning Definitions of Aortic Stenosis Severity with Treatment Recommendations

State-of-the-Art in ACS and STEMI: Risk Stratification, Reperfusion Strategies, and Guidelines

Guidelines for Performing a Comprehensive Transesophageal Echocardiographic Examination

Left Main Revascularization in the United States: Guidelines, Appropriate Use Criteria, and Standards of Care

European Standards for Left Main Revascularization: Does Clinical Practice Mirror Guidelines?

Appropriateness of Diagnostic Catheterization for Suspected CAD in NY State

The Current US Guidelines Are Poorly Conceived! What Is Really Required to Be an Optimal TAVR Site?

The DAPT Duration Dilemma: Recent Trials and Reasonable Guidelines for Clinical Practice

Guidelines for Commercial TAVR Site Selection in the United States

Medical Device Industry Perspectives

From Evidence-Based Medicine to Guidelines (and Appropriate Use Criteria) to Clinical Practice

Welcome and Introduction: The Purpose of the FDA Town Hall Meeting

Status Update on European Medical Device Regulatory Reform Initiatives

Keynote Address: The Intersection of Innovation, Payment and Regulatory Approval in the Future of Interventional Cardiology

Keynote Address: FDA-CDRH in the Next Decade – A Vision for Change

Interventional Cardiovascular Medicine Perspectives

FDA-CDRH Perspectives

Enlightened Perspectives from NICE

Cool and Cath: Critical Appraisal of the New Guidelines

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content